AGIO vs FTRE
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
AGIO · Agios Pharmaceuticals$27.60 ▼ 4.03%
FTRE · Fortrea Holdings$18.55 ▼ 7.94%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- AGIO +4.2%
- FTRE +55.2%
Head to head
| Metric | AGIO | FTRE |
|---|---|---|
| Price | $27.60 | $18.55 |
| Change today | ▼ 4.03% | ▼ 7.94% |
| Market cap | $1.65B | $1.79B |
| Return, 3 months | -15.4% | +1.3% |
| Return, year to date | +1.4% | +7.5% |
| Return, 1 year | +9.4% | +70.2% |
| P/E (TTM) | – | – |
| P/B | 1.7 | 3.4 |
| P/E percentile vs own 5y | 48th | 14th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +330.0% | -1.4% |
| Net profit growth (YoY) | +37.1% | +103.8% |
| Gross margin | 93.8% | 20.0% |
| Operating margin | -297.7% | 1.7% |
| Net margin | -264.8% | -2.6% |
| Return on equity | -32.9% | -12.3% |
| Analyst target vs. price | +65.9% | +35.5% |
| Analyst buy share | 67% | 64% |
| RSI (14) | 35 | 37 |
| 30-day volatility | 86.1% | 70.0% |
| Max drawdown, 1 year | -50.9% | -51.8% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- FTRE is the largest of the group by market value.
- FTRE has returned the most over the past year.
- AGIO is growing revenue fastest.
- FTRE keeps the most profit per dollar of sales.
- FTRE has been the calmest stock over the last 30 days.